announced today that it has completed patient enrollment in its Phase 2 clinical trial for Purified Exosome Product™ (PEP™) in the treatment of Diabetic Foot Ulcers (DFUs). This milestone ...
Diabetic foot screening intervals could be extended beyond 1 year for patients at very low risk for diabetic foot complications.
Hosted on MSN8d
Diabetic FootDr MKO AbimbolaDiabetes is a long-term condition caused by deficiency in quantity or function of insulin, the chemical controlling the level of sugar in the blood. People with diabetes particularly ...
However, the effect of mesenchymal stem cells or their exosomes on macrophage efferocytosis of dying heart-muscle cells—in animal models with or without diabetes—has not been studied, Krishnamurthy ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback